Pathogenetic insights into young-onset Parkinson disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Manganese and Vanadium Co-Exposure Induces Severe Neurotoxicity in the Olfactory System: Relevance to Metal-Induced Parkinsonism.International journal of molecular sciences · 2024
   Article
2. Different risks of early-onset and late-onset Parkinson disease in individuals with mental illness.NPJ Parkinson's disease · 2024
   Article
3. Are the digit ratio (2D:4D) and hand grip strength related to Parkinson disease in elderly males?BMC sports science, medicine & rehabilitation · 2023
   Article
4. Diagnostic pitfalls in young onset parkinsonism and its unique challenges: A case report from rural Nepal.SAGE open medical case reports · 2023
   Article
5. Incidence of Parkinson disease in North America.NPJ Parkinson's disease · 2022
   Article

Corrections and comments

• Comment on
  iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates.2020

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as